When Research Funding Is Cut, Who Really Pays the Price?

This week, Dr. Oni Blackstock raised a question that deserves more than a moment of attention. It deserves a deeper examination of how decisions around research funding shape not only careers, but whose lives and communities are ultimately prioritized in science and medicine.

A newly published study in Proceedings of the National Academy of Sciences (PNAS) found that recent NIH funding cuts disproportionately impacted women and early-career researchers. These cuts were not minor disruptions. More than 2,000 grants were terminated, halting billions of dollars in research already in motion. For many early-career scientists, these grants were not just one of many funding streams. They were the foundation of their work, their teams, and their future in research.

But as Dr. Blackstock pointed out, the study only scratches the surface of what is really happening.

It does not fully account for what happens when these cuts intersect with long-standing inequities in who gets funded in the first place. It does not answer what happens to those navigating multiple layers of marginalization, including Black women and other researchers of color who are already underrepresented in scientific research and historically underfunded.

To understand the real impact of these cuts, we have to start with what we already know.

For years, data has shown that Black researchers are significantly less likely to receive NIH funding than their white counterparts, even when controlling for education, training, and institutional affiliation. Research has also found that topics often studied by Black scientists, including community health, health disparities, and structural inequities, are less likely to be funded across the board. This means that inequity is not just about who is in the room. It is also about which questions are considered worthy of investment.

When funding is cut, those disparities do not disappear. They deepen.

And for some researchers, this is not theoretical. It is personal and immediate.

Dr. Jaime Slaughter-Acey, a Black epidemiologist at the University of North Carolina, lost a $2.4 million NIH grant focused on Black maternal health while her study was already underway. The research included hundreds of Black women and aimed to better understand how racism, stress, and lived experience shape birth outcomes. When the funding was cut, the work did not simply pause. Critical data collection, analysis, and potential solutions were disrupted in real time.

Similarly, a Duke University researcher studying sickle cell disease saw a $750,000 grant terminated and spoke publicly about the decision, calling attention to how these cuts disproportionately impact research tied to Black communities. The story circulated widely, resonating not just within academic circles but across broader public conversations about equity, science, and whose health is prioritized.

These examples reflect a broader pattern. Recent data shows that fellowship awards to Black researchers dropped by approximately 40 percent in a single year, compared to a 9 percent decline for white researchers. At the same time, NIH cuts have eliminated billions of dollars in research funding overall, creating a landscape where fewer resources are available and competition becomes even more intense.

In that environment, those who already face barriers are often the first to feel the impact and the least likely to recover from it.

For early-career researchers, the loss of a single grant can mean the loss of an entire trajectory. For Black researchers, who are less likely to hold multiple grants simultaneously, there is often no cushion to absorb that loss. For Black women in particular, who sit at the intersection of both racial and gender disparities in funding, the consequences can be even more profound, even if the data has yet to fully capture it.

This is why the question Dr. Blackstock raised matters so much.

Because without disaggregated data that reflects the full complexity of identity, we risk underestimating the true impact of these funding decisions. We risk telling a partial story that obscures who is being pushed out of the research pipeline and whose work is being left unfinished.

And this is not just about researchers. It is about the future of science and the health of our communities.

When funding is pulled from studies focused on maternal health, chronic disease, and community-based interventions, the consequences extend far beyond academic institutions. They show up in gaps in care, in delayed breakthroughs, and in the continued marginalization of communities that are already underserved.

The question before us is not simply whether funding cuts are happening. It is whether we are willing to confront how those cuts land and who they leave behind.

Dr. Blackstock did not just highlight a study. She challenged us to think more critically about the systems we rely on and the outcomes they produce.

If we are serious about advancing equity in research and health, then we must be equally serious about understanding who is most impacted when support is withdrawn. Because when we lose researchers who are closest to the problems, we lose the very solutions we claim to be seeking.

Sources

Proceedings of the National Academy of Sciences. “Impact of NIH Grant Terminations on Researchers” (2025). https://www.pnas.org/doi/10.1073/pnas.2527755123

Ginther, D.K. et al. “Race, Ethnicity, and NIH Research Awards.” Science 333, no. 6045 (2011): 1015–1019. https://doi.org/10.1126/science.1196783

Erosheva, E.A., et al. “NIH Peer Review: Criterion Scores Completely Account for Racial Disparities in Overall Impact Scores.” Science Advances 6, no. 23 (2020). https://doi.org/10.1126/sciadv.aaz4868

Stat News. “NIH Cuts Disproportionately Affect Women, Black Researchers, and Early-Career Scientists” (2026).

The Guardian. “Black Maternal Health Research Disrupted by NIH Cuts” (2025).

Association of American Universities. “NIH Has Canceled Billions in Research Grants” (2025).